The Intellectual Property and Science business of Thomson Reuters, the world's leader in intelligent information for businesses and professionals, today released the 2015 edition of its annual Drugs to Watch report.
from The Medical News http://ift.tt/1FQJA23
from The Medical News http://ift.tt/1FQJA23
No comments:
Post a Comment